Demonstrates improved chemical speciation of lead in biological systems, indicating effective detection methods.
Lead exposure remains a major global health concern, contributing to an estimated 1.5% of annual deaths worldwide and causing widespread, irreversible neurodevelopmental and cardiovascular damage, particularly in children. A central challenge in understanding and mitigating lead toxicity is the determination of its chemical speciation in complex biological and environmental systems, where conventional Pb LIII-edge X-ray absorption spectroscopy (XAS) is fundamentally limited by severe core-hole lifetime broadening. Here we show that Pb Lα1 high-energy-resolution fluorescence-detected X-ray absorption spectroscopy (HERFD-XAS) provides a practical and experimentally accessible route to overcoming this limitation. Pb Lα1 HERFD-XAS yields an approximately 2-fold improvement in spectral resolution relative to conventional XAS, enabling enhanced sensitivity for quantitative speciation in heterogeneous and dilute systems. The method shows negligible chemical shifts (<0.06 eV) in the emission energy, simplifying implementation, distinguishes holodirected and hemidirected Pb(II) coordination environments, resolves biologically relevant Pb binding modes in zinc-finger model peptides, and identifies hemidirected Pb-substitution in hydroxyapatite, a key long-term reservoir of lead in humans. These results establish Pb Lα1 HERFD-XAS as a sensitive and experimentally accessible tool for determining Pb speciation in environmental and biological systems.
No takes yet. Share an insight, caveat, or question.
Huntsman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: